About Coagulation factor IX
Coagulation factor IX (F9) is a protein
from Homo sapiens identified by UniProt accession
P00740, 461 residues long.
MolForge cross-references it against 0 known binders and
280 disease associations.
Target properties
| Protein name | Coagulation factor IX |
| UniProt accession | P00740 |
| Gene | F9 |
| Organism | Homo sapiens |
| Length | 461 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (280)
Diseases linked to this target (Open Targets).
- hemophilia B · score 0.89
- hemophilia A · score 0.76
- thrombophilia, X-linked, due to factor 9 defect · score 0.73
- Venous thrombosis · score 0.68
- x-linked warfarin sensitivity · score 0.61
- hemophilia b leyden · score 0.50
- hemorrhage · score 0.46
- severe hemophilia B · score 0.45
- Abnormality of coagulation · score 0.44
- severe hemophilia A · score 0.43
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P00740-F1 | alphafold | PREDICTED | 80.29 | — |
Amino-acid sequence (461 residues)
MQRVNMIMAE SPGLITICLL GYLLSAECTV FLDHENANKI LNRPKRYNSG KLEEFVQGNL ERECMEEKCS FEEAREVFEN TERTTEFWKQ YVDGDQCESN PCLNGGSCKD DINSYECWCP FGFEGKNCEL DVTCNIKNGR CEQFCKNSAD NKVVCSCTEG YRLAENQKSC EPAVPFPCGR VSVSQTSKLT RAETVFPDVD YVNSTEAETI LDNITQSTQS FNDFTRVVGG EDAKPGQFPW QVVLNGKVDA FCGGSIVNEK WIVTAAHCVE TGVKITVVAG EHNIEETEHT EQKRNVIRII PHHNYNAAIN KYNHDIALLE LDEPLVLNSY VTPICIADKE YTNIFLKFGS GYVSGWGRVF HKGRSALVLQ YLRVPLVDRA TCLRSTKFTI YNNMFCAGFH EGGRDSCQGD SGGPHVTEVE GTSFLTGIIS WGEECAMKGK YGIYTKVSRY VNWIKEKTKL T
Explore Coagulation factor IX with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets